Cargando…
Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies
The on-target toxicity of monoclonal antibodies (Abs) is mainly due to the fact that Abs cannot distinguish target antigens (Ags) expressed in disease regions from those in normal tissues during systemic administration. In order to overcome this issue, we “copied” an autologous Ab hinge as an “Ab lo...
Autores principales: | Huang, Bo-Cheng, Lu, Yun-Chi, Liao, Jun-Min, Liu, Hui-Ju, Hong, Shih-Ting, Hsieh, Yuan-Chin, Chuang, Chih-Hung, Chen, Huei-Jen, Liao, Tzu-Yi, Ho, Kai-Wen, Wang, Yeng-Tseng, Cheng, Tian-Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293997/ https://www.ncbi.nlm.nih.gov/pubmed/34349949 http://dx.doi.org/10.1039/d1sc01748a |
Ejemplares similares
-
Correction: Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies
por: Huang, Bo-Cheng, et al.
Publicado: (2021) -
Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains
por: Chen, I-Ju, et al.
Publicado: (2017) -
Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy
por: Lin, Wen-Wei, et al.
Publicado: (2021) -
A molecular dynamics simulation study decodes the Zika virus NS5 methyltransferase bound to SAH and RNA analogue
por: Chuang, Chih-Hung, et al.
Publicado: (2018) -
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy
por: Lu, Yun-Chi, et al.
Publicado: (2019)